216 related articles for article (PubMed ID: 32805688)
21. MicroRNA involvement in the pathogenesis and management of breast cancer.
Khoshnaw SM; Green AR; Powe DG; Ellis IO
J Clin Pathol; 2009 May; 62(5):422-8. PubMed ID: 19398594
[TBL] [Abstract][Full Text] [Related]
22. Circulating microRNAs for the prediction of metastasis in breast cancer patients diagnosed with early stage disease.
Inns J; James V
Breast; 2015 Aug; 24(4):364-9. PubMed ID: 25957467
[TBL] [Abstract][Full Text] [Related]
23. MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance and Applications in Human Triple-Negative Breast Cancer.
Ding L; Gu H; Xiong X; Ao H; Cao J; Lin W; Yu M; Lin J; Cui Q
Cells; 2019 Nov; 8(12):. PubMed ID: 31766744
[TBL] [Abstract][Full Text] [Related]
24. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
25. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.
Rodríguez-Martínez A; de Miguel-Pérez D; Ortega FG; García-Puche JL; Robles-Fernández I; Exposito J; Martorell-Marugan J; Carmona-Sáez P; Garrido-Navas MDC; Rolfo C; Ilyine H; Lorente JA; Legueren M; Serrano MJ
Breast Cancer Res; 2019 Feb; 21(1):21. PubMed ID: 30728048
[TBL] [Abstract][Full Text] [Related]
26. Suppressing the molecular signaling pathways involved in inflammation and cancer in breast cancer cell lines MDA-MB-231 and MCF-7 by miR-590.
Sheikholeslami A; Nabiuni M; Arefian E
Tumour Biol; 2017 Apr; 39(4):1010428317697570. PubMed ID: 28443471
[TBL] [Abstract][Full Text] [Related]
27. The role of oncomirs in the pathogenesis and treatment of breast cancer.
Hemmatzadeh M; Mohammadi H; Jadidi-Niaragh F; Asghari F; Yousefi M
Biomed Pharmacother; 2016 Mar; 78():129-139. PubMed ID: 26898434
[TBL] [Abstract][Full Text] [Related]
28. Cross-Roads to Drug Resistance and Metastasis in Breast Cancer: miRNAs Regulatory Function and Biomarker Capability.
Naser Al Deen N; Nassar F; Nasr R; Talhouk R
Adv Exp Med Biol; 2019; 1152():335-364. PubMed ID: 31456193
[TBL] [Abstract][Full Text] [Related]
29. ATF-3/miR-590/GOLPH3 signaling pathway regulates proliferation of breast cancer.
Song Q; Chen Q; Wang Q; Yang L; Lv D; Jin G; Liu J; Li B; Fei X
BMC Cancer; 2018 Mar; 18(1):255. PubMed ID: 29534690
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
[TBL] [Abstract][Full Text] [Related]
31. microRNAs in breast cancer development and treatment.
Serpico D; Molino L; Di Cosimo S
Cancer Treat Rev; 2014 Jun; 40(5):595-604. PubMed ID: 24286642
[TBL] [Abstract][Full Text] [Related]
32. Serum microRNA-21 expression as a prognostic and therapeutic biomarker for breast cancer patients.
Yadav P; Mirza M; Nandi K; Jain SK; Kaza RC; Khurana N; Ray PC; Saxena A
Tumour Biol; 2016 Nov; 37(11):15275-15282. PubMed ID: 27696295
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets.
Huang J; Zhang SY; Gao YM; Liu YF; Liu YB; Zhao ZG; Yang K
Cell Prolif; 2014 Aug; 47(4):277-86. PubMed ID: 24909356
[TBL] [Abstract][Full Text] [Related]
34. microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy.
Kanchan RK; Siddiqui JA; Mahapatra S; Batra SK; Nasser MW
Mol Cancer; 2020 Feb; 19(1):29. PubMed ID: 32059676
[TBL] [Abstract][Full Text] [Related]
35. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
Wang YW; Zhang W; Ma R
Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
[TBL] [Abstract][Full Text] [Related]
36. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
[TBL] [Abstract][Full Text] [Related]
37. The role of microRNAs in human breast cancer progression.
Zhang W; Liu J; Wang G
Tumour Biol; 2014 Jul; 35(7):6235-44. PubMed ID: 24938874
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction.
Nassar FJ; Nasr R; Talhouk R
Pharmacol Ther; 2017 Apr; 172():34-49. PubMed ID: 27916656
[TBL] [Abstract][Full Text] [Related]
39. Exosomal microRNA: a novel biomarker for breast cancer.
He Y; Deng F; Yang S; Wang D; Chen X; Zhong S; Zhao J; Tang J
Biomark Med; 2018 Feb; 12(2):177-188. PubMed ID: 29151358
[TBL] [Abstract][Full Text] [Related]
40. miRNAs in breast cancer: ready for real time?
Krell J; Frampton AE; Jacob J; Castellano L; Stebbing J
Pharmacogenomics; 2012 Apr; 13(6):709-19. PubMed ID: 22515613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]